Pulling SEC filings + quote and writing the call…
NUVB
Nuvation Bio Inc.
Next earnings Aug 5, 2026 · consensus $-0.19 EPS, $27.7M rev
Last earnings -1.8% on 2026-05-04
$5.76
▲ +3.60%$5.76▲ +209.68%
over 1Y
L $1.71EODHDH $9.54
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+3.6%
1W+12.1%
1M+22.8%
3M+32.4%
YTD-32.9%
1Y+209.7%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 17 analysts
Buy
Revenue grew 699.0% YoY; but unprofitable (net margin -325.3%).
Nuvation Bio Inc. shows $62.9M in FY2025 revenue (+699.0% YoY), a -325.3% net margin, and -66.9% ROE.
Sources: SEC EDGAR (CIK 0001811063, latest 10-Q filed 2026-05-04) · EODHD · as of 6/22/2026, 8:54:45 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.